Rad AI has secured $8 million in its latest funding round, which it plans to use to further improve and market its AI tools for more efficient radiology workflows.
The round was led by four health systems: Advocate Health, Memorial Hermann Health System, Corewell Health, and Atlantic Health System. The additional investment brings Rad AI’s total Series C funding to $68 million.
Rad AI said that the resulting partnerships will make ways for system-wide adoption of advanced radiology and follow-up software. The company's AI product portfolio includes Rad AI Impressions, Omni Unchanged, Omni Report, and Rad AI Continuity.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
